Taking away the large burden of wound healing

KINETIC Concepts (KCI) has launched its large instillation dressing for easy application of V.A.C. VeraFlo Instillation Therapy on larger wounds and wounds requiring additional dressing customization.

The introduction of the V.A.C. VeraFlo Large Dressing complements the dressing product line, so that clinicians can choose from a complete portfolio of instillation dressings to treat wounds of various sizes and complexities.

“Clinicians tell us they are experiencing the ‘wow’ effect when using V.A.C. VeraFlo Therapy on their patients,” said Ron Silverman, MD, chief medical officer, KCI. “The launch of the new large dressing means it becomes even easier to apply instillation therapy to different types of wounds.”

KCI recently demonstrated its commitment and investment in the future of V.A.C. VeraFlo Therapy as a better treatment option for customers and patients by announcing the initiation of patient enrollment in a multi-center clinical study assessing the benefits of negative pressure wound therapy (NPWT) with intermittent instillation therapy using a topical wound cleanser.

This study follows an independent retrospective, historical cohort-controlled study recently presented at the 2013 Technology Innovations in Plastic Surgery meeting in San Francisco, California by physicians from MedStar Georgetown University Hospital, Center for Wound Healing, led by Christopher E. Attinger, M.D., chief, Division of Wound Healing. [1]

The results, involving 142 patients, demonstrated the effectiveness of V.A.C. VeraFlo Therapy with instillation with Prontosan[2] Wound Irrigation Solution compared to V.A.C. Therapy in the adjunctive treatment of wounds that required hospital admission and serial surgical debridement. The results of this study suggested a significant decrease in operating room visits for study patients who received V.A.C. VeraFlo Therapy with Prontosan Wound Irrigation Solution instillation. Further, the investigators reported a trend toward a two- to three-day reduction in hospital stay compared to traditional V.A.C. Therapy in these patients.

This growing body of evidence, combined with the launch of the V.A.C. VeraFlo Large Dressing, contributes to better treatment options for customers and patients.

 [1] Powers KA, Kim PJ, Attinger CE, et al. Early Experience with Negative Pressure Wound Therapy with  Instillation in Acutely Infected Wounds. Presented at the 2013 Technology Innovations in Plastic Surgery Conference, May 31-June 2, 2013, San Francisco, CA.

[2] Prontosan is a trademark of B.Braun Medical, Inc.